- August 30, 2022
- Taiho Pharmaceutical Co., Ltd.
Taiho Pharmaceutical Launches Solmack® Q-Arl S, a New Addition to the Solmack Line of Products for Skin Problems and Hangover Tiredness Associated with Malnutrition
Taiho Pharmaceutical Co., Ltd. announced today that it launched Solmack® Q-Arl S, a designated quasi-drug, in pharmacies and drugstores throughout Japan starting August 30, 2022. Solmack Q-Arl S is effective for skin problems (rough skin, dry skin) and hangover tiredness associated with malnutrition in daily life.
-
-
- 4 tablets (2 doses) 20 tablets (10 doses)
-
Since its launch in 1979, the Solmack series has been sold for more than 40 years to treat the nausea caused by overeating, overdrinking, hangovers, and other unpleasant aftereffects of drinking too much. Solmack Q-Arl S is the latest addition to the Solmack series, which contains L-cysteine and vitamins as active ingredients. L-cysteine supports alcohol metabolism which improves and prevents the tiredness associated with hangovers, while L-cysteine and vitamins improve and prevent skin problems (rough skin, dry skin), an effect different from that of conventional Solmack.
Two types of packages are available: 4 tablets (2 doses) and 20 tablets (10 doses). It is easy to carry around and the tablets are easy to take.
Solmack Q-Arl S supports people who are concerned in daily life about skin problems and the tiredness associated with hangovers from drinking too much.
Taiho Pharmaceutical will continue to create a chain of “smiles” by exploring people’s true needs and creating innovative products to meet such needs.
Product Features
- L-cysteine supports alcohol metabolism, improving and preventing tiredness associated with hangovers
- L-cysteine and vitamins improve and prevent skin problems (rough skin, dry skin)
- Pouch bag with zipper for easy carrying (20 tablets, 10 doses)
Product Overview
|
Brand name |
Solmack® Q-Arl S |
|
Risk categories |
Designated quasi-drug |
|
Active ingredients (1 day’s dose / 2 tablets) |
Ascorbic Acid (Vitamin C)…300 mg |
|
Dosage and administration |
Take the following doses with cold or warm water. |
|
Indication |
◆Improvement and prevention of poor health associated with malnutrition in daily life |
|
Suggested retail price |
4 tablets (2 dose): JPY 330 (JPY300 excluding tax) |
|
Launch date |
August 30, 2022 |
|
Manufacturer and distributor |
Kyoto Pharmaceutical Industries, Ltd. |
|
Distributor |
Taiho Pharmaceutical Co., Ltd. |
Information in this news release was current as of the original release date.
Taiho Pharmaceutical's press releases may contain information about prescription drugs including products currently under development, however information contained in the press releases are not intended to constitute promotion, advertisement, or medical advice.